Onternabez Explained
Onternabez (also known as HU-308, HU308, PPP-003, and ARDS-003) is a synthetic cannabinoid that acts as a potent cannabinoid agonist. It is highly selective for the cannabinoid-2 receptor (CB2 receptor) subtype, with a selectivity more than 5,000 times greater for the CB2 receptor than the CB1 receptor.[1] [2] [3] The synthesis and characterization of onternabez took place in the laboratory of Raphael Mechoulam at the Hebrew University of Jerusalem (the HU in HU-308) in the late 1990s. The pinene dimethoxy-DMH-CBD derivative onternabez was identified as a potent peripheral CB2-selective agonist in in vitro and animal studies in 1990 and 1999.
Legal status
Onternabez is non-psychoactive and not scheduled at the federal level in the United States.[4] It is a Schedule I controlled substance in the state of Florida making it illegal to buy, sell, or possess there.[5]
See also
Notes and References
- Mechoulam R, Lander N, Breuer A, Zahalka J . 1990-04-11. Synthesis of the individual, pharmacologically distinct enantiomers of a tetrahydrocannabinol derivative. Tetrahedron Asymmetry. 1. 5. en. 315โ318. 10.1016/S0957-4166(00)86322-3. free.
- Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, Fride E . 6 . HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor . Proceedings of the National Academy of Sciences of the United States of America . 96 . 25 . 14228โ14233 . December 1999 . 10588688 . 24419 . 10.1073/pnas.96.25.14228 . free . 1999PNAS...9614228H .
- Web site: Properties of HU-308 ~ Formula C27H42O3 . Pitt Quantum Repository . University of Pittsburgh Department of Chemistry.
- Web site: 21 CFR โ Schedules of controlled substances ยง1308.11 Schedule I. . 2014-12-17 . 2009-08-27 . https://web.archive.org/web/20090827043725/http://www.deadiversion.usdoj.gov/21cfr/cfr/1308/1308_11.htm . dead .
- Web site: Chapter 893 - Drug abuse prevention and control . Florida Statutes .